Moreover, IGF2BP2 may also be involved in pathological conditions preceding HCC, such as nonalcoholic fatty liver disease (NAFLD) [110]. This evidence concerns the gene IGF2BP2 and metabolic dysfunction-associated steatotic liver disease.